Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
NMRA	NEUMORA THERAPEUTICS INC	$349.22M	-113.80%	-96.90%	-154.89%	-242.80%	0.35	6.85	N/A	N/A	N/A
VERU	VERU INC	$35.45M	-137.20%	-81.60%	-155.40%	-430.50%	0.78	2.42	40.40%	-491.40%	-482.04%
ABEO	ABEONA THERAPEUTICS INC	$290.47M	78.40%	48.00%	41.45%	86.10%	0.35	9.74	-22.00%	20,587.50%	21,650.75%
IFRX	INFLARX NV	$71.13M	-68.50%	-53.20%	-86.90%	-104.20%	0.44	3.33	-8,223.10%	-63,818.90%	-63,757.59%
IMUX	IMMUNIC INC	$74.82M	-716.20%	-252.10%	-969.85%	507.30%	2.88	1.31	N/A	N/A	N/A
ALVO	ALVOTECH	$1.74B	-26.10%	5.30%	20.46%	10.40%	-8.97	1.42	55.60%	12.10%	39.44%
AGIO	AGIOS PHARMACEUTICALS INC	$1.59B	-28.40%	-26.40%	-31.29%	-28.90%	0.08	13.82	87.20%	-895.90%	-915.68%
RNAC	CARTESIAN THERAPEUTICS INC	$221.55M	N/A	-12.60%	-13.29%	-27.00%	-11.40	10.67	100.00%	-4,638.60%	-4,371.40%
INO	INOVIO PHARMACEUTICALS INC	$110.36M	-307.60%	-127.90%	24,665.13%	-846.50%	-9.99	0.79	100.00%	-59,281.70%	-59,281.69%
GBIO	GENERATION BIO CO	$36.59M	-94.80%	-34.10%	-62.10%	-34.60%	1.41	4.44	100.00%	-410.10%	-410.13%
NCEL	NEWCELX LTD	$1.21M	N/A	-337.50%	N/A	363.90%	0.51	N/A	N/A	N/A	N/A
AMIX	AUTONOMIX MEDICAL INC	$5.05M	-213.40%	-172.60%	-257.56%	1,440.30%	0.23	5.31	N/A	N/A	N/A
IMNN	IMUNON INC	$12.74M	-501.10%	-166.80%	-299.16%	239,282.00%	1.20	1.73	N/A	N/A	N/A
RZLT	REZOLUTE INC	$166.91M	-62.80%	-57.10%	-51.99%	-81.70%	0.08	15.15	N/A	N/A	N/A
CAPR	CAPRICOR THERAPEUTICS INC	$1.19B	-71.00%	-56.10%	-83.42%	-78.10%	0.51	3.59	100.00%	-736.60%	-736.62%
ORIC	ORIC PHARMACEUTICALS INC	$913.51M	-45.30%	-41.80%	-32.91%	-55.20%	0.06	14.65	N/A	N/A	N/A
VVOS	VIVOS THERAPEUTICS INC	$18.61M	-351.30%	-87.40%	-93.94%	-180.60%	9.13	0.78	55.70%	-98.80%	-98.77%
DMAC	DIAMEDICA THERAPEUTICS INC	$489.01M	-83.30%	-73.60%	-61.70%	-90.10%	0.11	10.67	N/A	N/A	N/A
EYPT	EYEPOINT PHARMACEUTICALS INC	$1.32B	-76.10%	-61.70%	-92.76%	-87.80%	0.26	7.18	94.10%	-486.00%	-485.49%
BCAX	BICARA THERAPEUTICS INC	$1.01B	-27.20%	-26.00%	-30.02%	-205.00%	0.05	14.14	N/A	N/A	N/A
DRTS	ALPHA TAU MEDICAL LTD	$429.47M	-51.20%	-38.20%	-31.98%	-37.50%	0.28	10.52	N/A	N/A	N/A
BTAI	BIOXCEL THERAPEUTICS INC	$43.96M	N/A	-185.00%	-738.28%	-61.10%	-1.50	1.18	-28.20%	-9,070.60%	-6,860.51%
CADL	CANDEL THERAPEUTICS INC	$348.60M	-29.20%	-22.60%	-26.21%	353.60%	0.17	8.25	N/A	N/A	N/A
STXS	STEREOTAXIS INC	$221.18M	-597.20%	-55.60%	-93.69%	-298.10%	5.44	1.31	53.10%	-82.80%	-78.56%
RMTI	ROCKWELL MEDICAL INC	$36.45M	-16.80%	-9.90%	-9.16%	-13.10%	0.55	3.92	15.10%	-7.30%	-5.81%
ELDN	ELEDON PHARMACEUTICALS INC	$98.29M	-94.90%	-49.30%	-65.03%	-56.80%	1.10	6.74	N/A	N/A	N/A
GUTS	FRACTYL HEALTH INC	$306.98M	-3,645.20%	-133.00%	-127.83%	-149.70%	-36.96	4.27	100.00%	-4,073,233.30%	-4,073,233.33%
BCAB	BIOATLA INC	$48.44M	N/A	-193.50%	3,116.91%	1,007.10%	-1.51	0.54	N/A	N/A	N/A
IRON	DISC MEDICINE INC	$3.47B	-31.60%	-29.00%	-29.38%	-36.40%	0.10	23.45	N/A	N/A	N/A
OSRH	OSR HOLDINGS INC	$16.43M	N/A	N/A	N/A	N/A	0.53	0.21	N/A	N/A	N/A
ZURA	ZURA BIO LTD	$261.39M	-48.20%	-38.30%	-54.26%	359.10%	0.24	5.58	N/A	N/A	N/A
PRQR	PROQR THERAPEUTICS NV	$250.97M	-58.40%	-29.30%	-44.87%	-9,969.30%	1.18	3.36	100.00%	-264.80%	-254.60%
ELAB	PMGC HOLDINGS INC	$2.86M	-82.90%	-63.50%	-70.06%	-523.90%	0.76	1.79	82.20%	458.40%	454.25%
DNLI	DENALI THERAPEUTICS INC	$2.64B	-46.30%	-41.00%	-51.65%	-47.40%	0.14	9.79	N/A	N/A	N/A
SNDA	SONIDA SENIOR LIVING INC	$582.25M	-96.10%	-6.20%	-1.06%	-0.60%	25.81	0.70	21.50%	-13.90%	-2.13%
GCTK	GLUCOTRACK INC	$5.22M	-2,659.20%	-303.80%	-907.48%	1,929.70%	2.01	1.53	N/A	N/A	N/A
BHVN	BIOHAVEN LTD	$1.22B	-389.90%	-153.40%	-263.08%	-206.40%	-24.84	2.86	N/A	N/A	N/A
GNPX	GENPREX INC	$6.45M	-891.70%	-389.10%	-1,658.99%	-18,136.00%	3.64	0.67	N/A	N/A	N/A
CYTK	CYTOKINETICS INC	$7.75B	N/A	-56.50%	-54.98%	-36.10%	-3.76	6.88	100.00%	-862.20%	-816.07%
SGMT	SAGIMET BIOSCIENCES INC	$202.61M	-42.40%	-40.30%	-48.36%	-70.10%	0.08	13.06	N/A	N/A	N/A
TENX	TENAX THERAPEUTICS INC	$64.75M	-43.20%	-41.50%	-45.03%	1,681.90%	0.07	15.58	N/A	N/A	N/A
LFMD	LIFEMD INC	$163.66M	N/A	-10.80%	-22.51%	11.70%	47.64	0.73	87.00%	-3.10%	-0.83%
XENE	XENON PHARMACEUTICALS INC	$3.40B	-46.20%	-43.40%	-54.38%	-55.80%	0.09	12.53	100.00%	-4,084.50%	-4,129.39%
QNCX	QUINCE THERAPEUTICS INC	$234.98M	-370.50%	-50.80%	-67.86%	-133.70%	102.78	1.12	N/A	N/A	N/A
STRO	SUTRO BIOPHARMA INC	$83.69M	N/A	-73.40%	-155.14%	-202.80%	-3.40	2.53	100.00%	-205.20%	-202.30%
BMEA	BIOMEA FUSION INC	$99.69M	-310.10%	-145.40%	-241.56%	-1,835.00%	2.53	3.18	N/A	N/A	N/A
SINT	SINTX TECHNOLOGIES INC	$14.21M	-367.20%	-159.90%	-139.52%	-162.20%	1.79	1.70	23.50%	-1,304.20%	-770.87%
LUCD	LUCID DIAGNOSTICS INC	$159.71M	-781.30%	-169.50%	-197.32%	-1,081.40%	1.06	1.90	-58.10%	-1,496.80%	-1,210.75%
PDSB	PDS BIOTECHNOLOGY CORP	$47.71M	-209.00%	-83.30%	-150.77%	-287.10%	2.67	2.09	N/A	N/A	N/A
AVIR	ATEA PHARMACEUTICALS INC	$246.10M	-38.40%	-35.90%	-45.29%	-48.10%	0.09	16.66	N/A	N/A	N/A
KOD	KODIAK SCIENCES INC	$1.26B	-246.20%	-78.40%	-123.74%	-76.50%	8.20	1.79	N/A	N/A	N/A
VANI	VIVANI MEDICAL INC	$98.49M	-293.60%	-79.50%	-142.87%	-80.80%	18.13	0.61	N/A	N/A	N/A
CATX	PERSPECTIVE THERAPEUTICS INC	$198.48M	-39.10%	-33.20%	-39.26%	-49.80%	0.22	8.66	100.00%	-9,841.90%	-10,014.70%
GTBP	GT BIOPHARMA INC	$7.02M	-1,161.90%	-203.50%	-303.27%	392.30%	0.44	3.27	N/A	N/A	N/A
DNTH	DIANTHUS THERAPEUTICS INC	$1.81B	-33.00%	-31.10%	-22.82%	-34.90%	0.06	17.35	100.00%	-4,104.80%	-4,104.78%
XAIR	BEYOND AIR INC	$8.49M	-272.40%	-119.10%	-129.34%	-123.30%	1.40	4.24	-6.70%	-632.50%	-592.57%
NYXH	NYXOAH SA	$177.59M	-101.30%	-66.40%	-101.28%	-137.00%	0.84	1.70	64.40%	-1,484.70%	-1,308.30%
VIR	VIR BIOTECHNOLOGY INC	$930.75M	-50.80%	-40.60%	-52.89%	-55.50%	0.28	7.25	95.90%	-2,963.50%	-2,961.95%
NXL	NEXALIN TECHNOLOGY INC	$17.16M	-207.50%	-184.50%	-182.05%	-259.70%	0.08	13.47	69.50%	-5,530.40%	-5,531.56%
HOTH	HOTH THERAPEUTICS INC	$18.15M	-133.70%	-123.40%	-147.77%	-3,822.00%	0.12	8.81	N/A	N/A	N/A
AVTX	AVALO THERAPEUTICS INC	$337.29M	-88.40%	-73.90%	-86.18%	-288.20%	0.37	14.28	54.70%	-52,019.80%	-52,575.52%
SLDB	SOLID BIOSCIENCES INC	$457.33M	-73.60%	-60.00%	-70.12%	-112.70%	0.26	6.74	N/A	N/A	N/A
CCCC	C4 THERAPEUTICS INC	$239.38M	-64.40%	-38.70%	-51.82%	-44.80%	0.72	5.76	100.00%	-395.50%	-395.08%
VERA	VERA THERAPEUTICS INC	$3.18B	-50.90%	-42.70%	-51.39%	-43.50%	0.30	12.21	N/A	N/A	N/A
CVRX	CVRX INC	$221.48M	-84.50%	-42.10%	-46.13%	-69.50%	1.32	9.62	84.50%	-92.90%	-82.50%
KALA	KALA BIO INC	$5.54M	-2,323.90%	-87.00%	414.59%	-230.60%	-3.89	0.75	N/A	N/A	N/A
SHPH	SHUTTLE PHARMACEUTICALS HOLDINGS INC	$2.87M	-476.10%	-253.90%	-674.65%	-20,966.60%	1.54	1.66	N/A	N/A	N/A
AEMD	AETHLON MEDICAL INC	$2.59M	-241.80%	-169.90%	-190.07%	-2,465.70%	0.27	4.45	N/A	N/A	N/A
PMVP	PMV PHARMACEUTICALS INC	$65.45M	-55.30%	-51.00%	-69.86%	-78.60%	0.11	10.77	N/A	N/A	N/A
YDES	YD BIOPHARMA LTD	$869.18M	N/A	-12.30%	-20.99%	401.50%	0.04	13.18	30.40%	-276.60%	-271.52%
ENGN	ENGENE HOLDINGS INC	$431.24M	-39.90%	-34.20%	-40.52%	-44.20%	0.22	10.34	N/A	N/A	N/A
IOVA	IOVANCE BIOTHERAPEUTICS INC	$873.33M	-55.20%	-43.10%	-51.12%	-96.30%	0.29	3.41	24.00%	-158.80%	-159.06%
COCH	ENVOY MEDICAL INC	$23.17M	N/A	-286.10%	2,455.27%	-128.40%	-2.05	0.64	-294.20%	-13,755.30%	-9,525.96%
SNTI	SENTI BIOSCIENCES INC	$34.44M	-197.70%	-63.10%	-117.03%	-75.10%	5.49	1.51	N/A	N/A	N/A
LAB	STANDARD BIOTOOLS INC	$557.62M	-29.30%	-22.40%	-29.33%	-42.40%	0.35	4.38	47.90%	-99.60%	-98.29%
CDT	CDT EQUITY INC	$2.85M	-2,194.50%	-289.50%	-444.72%	-897.30%	1.00	1.66	N/A	N/A	N/A
ARTV	ARTIVA BIOTHERAPEUTICS INC	$81.00M	-50.00%	-44.00%	-57.49%	-52.80%	0.15	11.65	N/A	N/A	N/A
CDXS	CODEXIS INC	$150.84M	-121.40%	-47.40%	-53.78%	-37.00%	2.22	4.12	79.30%	-120.80%	-107.17%
KMTS	KESTRA MEDICAL TECHNOLOGIES LTD	$1.53B	-198.60%	-60.60%	-58.75%	-180.50%	0.50	5.47	46.40%	-186.90%	-166.90%
HOWL	WEREWOLF THERAPEUTICS INC	$53.39M	-144.40%	-71.70%	-109.10%	-184.00%	1.69	3.87	N/A	N/A	N/A
DCGO	DOCGO INC	$89.89M	-17.20%	-12.50%	-25.25%	-36.70%	0.34	2.59	31.20%	-14.00%	-19.22%
NVCT	NUVECTIS PHARMA INC	$194.42M	-155.40%	-99.90%	-115.81%	284.60%	0.48	3.07	N/A	N/A	N/A
AARD	AARDVARK THERAPEUTICS INC	$314.19M	-54.90%	-37.90%	-39.82%	-58.70%	0.09	12.04	N/A	N/A	N/A
LIMN	LIMINATUS PHARMA INC	$22.98M	N/A	N/A	N/A	N/A	-1.82	0.42	N/A	N/A	N/A
PRME	PRIME MEDICINE INC	$740.09M	-163.50%	-61.20%	-56.38%	-72.20%	1.38	6.61	100.00%	-3,301.60%	-3,301.64%
QNRX	QUOIN PHARMACEUTICALS LTD	$15.12M	-334.40%	-125.20%	-2,088.80%	-453.90%	-6.29	1.04	N/A	N/A	N/A
TRAW	TRAWS PHARMA INC	$18.62M	-2,912.00%	518.00%	2,048.95%	-1,528.40%	1.74	1.22	100.00%	3,280.00%	3,280.04%
ATOS	ATOSSA THERAPEUTICS INC	$106.57M	-49.40%	-44.80%	-60.62%	5,857.40%	0.17	6.77	N/A	N/A	N/A
SRRK	SCHOLAR ROCK HOLDING CORP	$4.78B	-122.00%	-86.50%	-100.33%	-144.60%	0.68	6.31	N/A	N/A	N/A
GRI	GRI BIO INC	$1.73M	-498.70%	-260.00%	-556.15%	711.60%	1.40	1.70	N/A	N/A	N/A
SPRC	SCISPARC LTD	$983.67k	396.50%	155.80%	13,168.14%	557.40%	-6.68	0.55	42.30%	1,312.80%	1,434.74%
OTLK	OUTLOOK THERAPEUTICS INC	$87.95M	N/A	-199.10%	476.73%	-544.00%	-1.60	0.67	70.80%	-2,885.80%	-2,881.12%
SNGX	SOLIGENIX INC	$16.64M	-267.10%	-135.70%	-149.12%	441.10%	0.49	3.18	N/A	N/A	N/A
NRIX	NURIX THERAPEUTICS INC	$1.47B	-53.60%	-40.80%	-55.44%	-52.30%	0.40	5.35	100.00%	-292.50%	-291.58%
CBUS	CIBUS INC	$87.40M	-166.90%	-34.90%	-27.31%	-31.10%	5.52	1.28	100.00%	-3,133.90%	-2,228.78%
PHGE	BIOMX INC	$3.48M	-68.40%	-35.00%	-51.75%	-43.60%	1.50	1.70	N/A	N/A	N/A
CTXR	CITIUS PHARMACEUTICALS INC	$19.05M	-62.80%	-33.70%	-51.63%	-60.40%	0.92	0.48	N/A	N/A	N/A
ABP	ABPRO HOLDINGS INC	$15.94M	N/A	-697.20%	68.47%	66.90%	-1.07	0.07	N/A	N/A	N/A
RCKT	ROCKET PHARMACEUTICALS INC	$366.87M	-62.40%	-53.90%	-70.95%	-83.00%	0.17	7.30	N/A	N/A	N/A
CRVO	CERVOMED INC	$78.19M	-76.80%	-68.10%	-98.36%	-106.60%	0.18	6.66	100.00%	-415.40%	-415.36%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	617	-0.42%	+0.28%	+6.65%	-45.18%	155.66x	5.32x	-29.26%	-10.76%	-20.60%	+47.99%	Strong Buy
Diagnostics & Research	57	-1.29%	-0.98%	+0.18%	+12.65%	22.53x	4.45x	-1.01%	+6.22%	+13.25%	+6.27%	Buy
Drug Manufacturers - General	20	+0.77%	-0.01%	+0.56%	+24.52%	44.67x	6.78x	+106.12%	+12.21%	+20.30%	+6.18%	Buy
Drug Manufacturers - Specialty & Generic	78	-0.05%	+0.96%	+2.43%	-6.16%	-1.56x	2.25x	+9.63%	+3.20%	+6.19%	+52.29%	Strong Buy
Healthcare Plans	10	+0.61%	+5.49%	+6.94%	-16.52%	43.49x	2.12x	+12.25%	+3.80%	+9.26%	+12.74%	Buy
Health Information Services	54	-1.63%	-0.64%	-0.91%	-42.17%	45.85x	3.99x	+8.14%	+4.50%	+6.03%	+32.65%	Strong Buy
Medical Care Facilities	50	+0.31%	+0.21%	+0.20%	-41.39%	15.44x	5.35x	-82.13%	+7.38%	+16.19%	+17.38%	Buy
Medical Devices	138	-0.55%	-1.36%	+0.80%	-32.53%	24.46x	3.88x	+11.73%	+7.10%	+8.12%	+22.90%	Strong Buy
Medical Distribution	11	+0.03%	+1.00%	-3.11%	+39.20%	31.36x	10,218.39x	-54.90%	+3.44%	+21.86%	+9.00%	Buy
Medical Instruments & Supplies	56	-0.48%	-0.78%	+1.80%	-31.26%	216.44x	3.70x	+9.94%	+8.52%	+11.25%	+14.91%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Dec 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Tactile Systems Technology (NASDAQ:TCMD)

Tactile Systems Technology (NASDAQ:TCMD) is the #1 top healthcare stock out of 1091 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Tactile Systems Technology (NASDAQ:TCMD) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: C, Financials: A, and AI: C.

Tactile Systems Technology (NASDAQ:TCMD) has a Due Diligence Score of 45, which is 19 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Tactile Systems Technology has seen its stock return 53.45% over the past year, overperforming other healthcare stocks by 83 percentage points.

Tactile Systems Technology has an average 1 year price target of $23.25, a downside of -16.43% from Tactile Systems Technology's current stock price of $27.82.

Tactile Systems Technology stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Tactile Systems Technology, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the #2 top healthcare stock out of 1091 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ironwood Pharmaceuticals (NASDAQ:IRWD) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: A.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a Due Diligence Score of 35, which is 9 points higher than the healthcare sector average of 26. It passed 11 out of 33 due diligence checks and has average fundamentals. Ironwood Pharmaceuticals has seen its stock return 0.56% over the past year, overperforming other healthcare stocks by 30 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $3.00, a downside of -16.2% from Ironwood Pharmaceuticals's current stock price of $3.58.

Ironwood Pharmaceuticals stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Ironwood Pharmaceuticals, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical (NASDAQ:COLL) is the #3 top healthcare stock out of 1091 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Collegium Pharmaceutical (NASDAQ:COLL) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: A.

Collegium Pharmaceutical (NASDAQ:COLL) has a Due Diligence Score of 49, which is 23 points higher than the healthcare sector average of 26. It passed 17 out of 33 due diligence checks and has strong fundamentals. Collegium Pharmaceutical has seen its stock return 61.62% over the past year, overperforming other healthcare stocks by 91 percentage points.

Collegium Pharmaceutical has an average 1 year price target of $49.50, an upside of 1.79% from Collegium Pharmaceutical's current stock price of $48.63.

Collegium Pharmaceutical stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Collegium Pharmaceutical, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 70 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 12.13%, which is 10 percentage points higher than the healthcare sector average of 1.84%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 9.39%, which is 8 percentage points higher than the healthcare sector average of 1.84%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) has an annual dividend yield of 5.08%, which is 3 percentage points higher than the healthcare sector average of 1.84%.

Embecta's dividend payout ratio of 36.6% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.44% in the last day, and down -0.02% over the last week. Sonnet Biotherapeutics Holdings was the among the top losers in the healthcare sector, dropping -59.35% yesterday.

Sonnet BioTherapeutics Holdings shares are trading lower after the company announced its stockholders approved a business combination with Hyperliquid Strategies and Rorschach I.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Organon & Co (NYSE:OGN)

Organon & Co (NYSE:OGN) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -53.29% in the past year. It has underperformed other stocks in the healthcare sector by -23 percentage points.

2. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -10.71% in the past year. It has overperformed other stocks in the healthcare sector by 19 percentage points.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 27.15% in the past year. It has overperformed other stocks in the healthcare sector by 57 percentage points.

Are healthcare stocks a good buy now?

55.36% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 27% over the next year.

7.58% of healthcare stocks have a Zen Rating of A (Strong Buy), 11.09% of healthcare stocks are rated B (Buy), 48.07% are rated C (Hold), 24.39% are rated D (Sell), and 8.87% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 64.49x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Tactile Systems Technology (NASDAQ:TCMD)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Collegium Pharmaceutical (NASDAQ:COLL)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Embecta (NASDAQ:EMBC)

1. Organon & Co (NYSE:OGN)

2. Bausch Health Companies (NYSE:BHC)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Tactile Systems Technology (NASDAQ:TCMD)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Collegium Pharmaceutical (NASDAQ:COLL)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Embecta (NASDAQ:EMBC)

1. Organon & Co (NYSE:OGN)

2. Bausch Health Companies (NYSE:BHC)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.